• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019冠状病毒病大流行对鼻咽癌患者的影响——一家国家癌症中心的经验

The impact of the COVID-19 pandemic on nasopharyngeal carcinoma patients - a national cancer centre experience.

作者信息

Poh Sharon S, Tan Boon Fei, Yong Fang Yue, Fong Kam Weng, Wee Joseph T S, Tan Terence W K, Chua Melvin L K, Sommat Kiattisa, Wang Fu Qiang, Soong Yoke Lim

机构信息

Division of Radiation Oncology, Duke-NUS Graduate Medical School, National Cancer Centre Singapore, Singapore, Singapore.

Duke-NUS Graduate Medical School, Oncology Academic Clinical Programme, Singapore, Singapore.

出版信息

Holist Integr Oncol. 2023;2(1):17. doi: 10.1007/s44178-023-00041-0. Epub 2023 Jun 7.

DOI:10.1007/s44178-023-00041-0
PMID:37520028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10244848/
Abstract

PURPOSE OR OBJECTIVE

The COVID-19 pandemic has resulted in significant healthcare implications, with care for cancer patients compromised due to resource diversion towards battling the pandemic. We aim to investigate the impact of the peak wave of the pandemic in 2020 on the delivery of cancer care in Singapore, specifically via our nasopharyngeal carcinoma (NPC) treatment data. This study applies real world numbers to the impact of COVID-19 on cancer care delivery in Singapore. The choice of nasopharyngeal cancer allows a good direct estimate of common treatment measures such as time to biopsy, time to staging scans, time to treatment commencement, due to its clear protocol and algorithms for staging and treatment; thus serving as an excellent surrogate for the effectiveness and timeliness of the different aspects of cancer care delivery.

MATERIALS AND METHODS

In this retrospective study, we included all patients with newly diagnosed NPC from 1st January to 31st May from 2017 to 2020 at our centre. This time period was chosen as it coincided with the period in 2020 during the COVID-19 pandemic where there was the most strain on healthcare resources and the most restrictions on population movement within Singapore, which may impact on healthcare seeking behaviour. Narrowing down the time period to the first 5 months of the 4 respective years also allowed us to reduce the effect of annual seasonal variation in patient numbers seen as a result of holidays and festive periods such as the Lunar New Year and scheduled school holidays. Electronic medical records (EMR) were accessed. Only newly diagnosed NPC cases were included in our analysis. Patients with second synchronous primary malignancies or NPC disease recurrence were excluded. Data analysis was carried out using a combination of SPSS and Microsoft Excel.

RESULTS

Significantly, there was a reduction of 37-46.3% in newly diagnosed NPC cases during the peak of the COVID-19 pandemic from January to end May 2020 compared to the preceding three years. Despite the reduction in numbers of newly diagnosed NPC, there was no statistically significant differences in delay from biopsy to the first radiation oncology visit and from biopsy to the first day of treatment in 2020 compared to the preceding years. All the patients treated in our centre also received the standard NPC treatment for their disease stage as per international guidelines.

CONCLUSION

We recommend a heightened awareness of the dangers of delaying cancer presentation and care in healthcare policies and resource allocation and at the same time, encourage patient's confidence in their ability to seek care. With the resurgence of new COVID-19 variants and case numbers worldwide and in Singapore, this study focuses upon the need to be aware of the exigencies of other clinical groups in resource utilization. It would be instructive to compare this study with future long term follow up to investigate the trajectory of our cancer care delivery, as well as survival outcomes.

摘要

目的或目标

新冠疫情对医疗保健产生了重大影响,由于资源转向抗击疫情,癌症患者的护理受到影响。我们旨在研究2020年疫情高峰期对新加坡癌症护理的影响,特别是通过我们的鼻咽癌(NPC)治疗数据。本研究将实际数据应用于新冠疫情对新加坡癌症护理的影响。选择鼻咽癌是因为其具有明确的分期和治疗方案及算法,能够很好地直接估计活检时间、分期扫描时间、开始治疗时间等常见治疗措施,从而成为癌症护理不同方面有效性和及时性的良好替代指标。

材料与方法

在这项回顾性研究中,我们纳入了2017年至2020年1月1日至5月31日在我们中心新诊断为鼻咽癌的所有患者。选择这个时间段是因为它与2020年新冠疫情期间相吻合,当时新加坡的医疗资源压力最大,人口流动限制也最多,这可能会影响就医行为。将时间段缩小到这四年各自的前5个月,还能减少因春节和学校假期等节假日导致的患者数量年度季节性变化的影响。我们查阅了电子病历(EMR)。分析仅纳入新诊断的鼻咽癌病例。排除患有第二原发性同步恶性肿瘤或鼻咽癌疾病复发的患者。使用SPSS和Microsoft Excel相结合的方式进行数据分析。

结果

值得注意的是,与前三年相比,2020年1月至5月底新冠疫情高峰期新诊断的鼻咽癌病例减少了37% - 46.3%。尽管新诊断的鼻咽癌病例数量有所减少,但与前几年相比,2020年从活检到首次放疗就诊以及从活检到治疗第一天的延迟在统计学上没有显著差异。在我们中心接受治疗的所有患者也都按照国际指南接受了针对其疾病阶段的标准鼻咽癌治疗。

结论

我们建议在医疗政策和资源分配中提高对延迟癌症就诊和护理风险的认识,同时鼓励患者对寻求护理的能力充满信心。随着全球及新加坡新冠病毒新变种的再度出现和病例数的增加,本研究强调了在资源利用方面需要关注其他临床群体的紧急情况。将本研究与未来的长期随访进行比较,以调查我们癌症护理的轨迹以及生存结果,将具有指导意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1898/10244848/4003e2162971/44178_2023_41_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1898/10244848/addfc88c1f43/44178_2023_41_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1898/10244848/867dbcafe958/44178_2023_41_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1898/10244848/4003e2162971/44178_2023_41_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1898/10244848/addfc88c1f43/44178_2023_41_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1898/10244848/867dbcafe958/44178_2023_41_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1898/10244848/4003e2162971/44178_2023_41_Fig3_HTML.jpg

相似文献

1
The impact of the COVID-19 pandemic on nasopharyngeal carcinoma patients - a national cancer centre experience.2019冠状病毒病大流行对鼻咽癌患者的影响——一家国家癌症中心的经验
Holist Integr Oncol. 2023;2(1):17. doi: 10.1007/s44178-023-00041-0. Epub 2023 Jun 7.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对远程早期检测 SARS-CoV-2 感染(COVID-RED)的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jun 22;22(1):412. doi: 10.1186/s13063-021-05241-5.
7
A rapid mixed-methods evaluation of remote home monitoring models during the COVID-19 pandemic in England.英格兰 COVID-19 大流行期间远程家庭监护模式的快速混合方法评估。
Health Soc Care Deliv Res. 2023 Jul;11(13):1-151. doi: 10.3310/FVQW4410.
8
A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort.EBV 血清学与血清游离细胞 DNA 作为鼻咽癌筛查工具的比较:新加坡鼻咽癌筛查队列研究结果。
Int J Cancer. 2020 May 15;146(10):2923-2931. doi: 10.1002/ijc.32774. Epub 2020 Jan 8.
9
The Effects of the COVID-19 Pandemic on Cancer Staging in Patients Diagnosed With Head and Neck Cancer.2019年冠状病毒病大流行对头颈癌确诊患者癌症分期的影响。
Cureus. 2023 Jan 25;15(1):e34190. doi: 10.7759/cureus.34190. eCollection 2023 Jan.
10
Impact of the COVID-19 pandemic on health-care use among patients with cancer in England, UK: a comprehensive phase-by-phase time-series analysis across attendance types for 38 cancers.英国英格兰地区2019冠状病毒病疫情对癌症患者医疗服务利用情况的影响:对38种癌症不同就诊类型的全面逐阶段时间序列分析
Lancet Digit Health. 2024 Oct;6(10):e691-e704. doi: 10.1016/S2589-7500(24)00152-3.

引用本文的文献

1
Advancing lung organoids toward clinical applications: a global perspective on research focus and future directions.推动肺类器官走向临床应用:关于研究重点和未来方向的全球视角。
Front Med (Lausanne). 2025 Jul 16;12:1611304. doi: 10.3389/fmed.2025.1611304. eCollection 2025.

本文引用的文献

1
Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France.由于 COVID-19,新诊断癌症患者的延迟治疗以及对法国癌症死亡率的估计影响。
ESMO Open. 2021 Jun;6(3):100134. doi: 10.1016/j.esmoop.2021.100134. Epub 2021 Apr 17.
2
Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review.由于 COVID-19 大流行导致的癌症医疗保健延误和中断:系统评价。
JCO Glob Oncol. 2021 Feb;7:311-323. doi: 10.1200/GO.20.00639.
3
Cancer Versus COVID-19: A Coordinated Disease Outbreak Response System (DORS) to Combat COVID-19 at the National Cancer Centre Singapore.
癌症与新冠肺炎:新加坡国立癌症中心应对新冠肺炎的协调疾病爆发应对系统(DORS)
Ann Acad Med Singap. 2020 Oct;49(10):807-809.
4
Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic.意大利北部和中部地区 2020 年因新冠疫情 lockdown 期间的癌症诊断延误。
Am J Clin Pathol. 2021 Jan 4;155(1):64-68. doi: 10.1093/ajcp/aqaa177.
5
Outcomes in Radiotherapy-Treated Patients With Cancer During the COVID-19 Outbreak in Wuhan, China.中国武汉 COVID-19 疫情期间接受放射治疗的癌症患者的结局。
JAMA Oncol. 2020 Sep 1;6(9):1457-1459. doi: 10.1001/jamaoncol.2020.2783.
6
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.《COVID-19 大流行对英国英格兰因诊断延误导致的癌症死亡人数的影响:一项全国性基于人群的建模研究》。
Lancet Oncol. 2020 Aug;21(8):1023-1034. doi: 10.1016/S1470-2045(20)30388-0. Epub 2020 Jul 20.
7
Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology.2020 年因 COVID-19 大流行而实行的“封锁”期间的癌症诊断率与 2018-2019 年相比:一项来自细胞病理学的审计研究。
J Clin Pathol. 2021 Mar;74(3):187-189. doi: 10.1136/jclinpath-2020-206833. Epub 2020 Jun 19.
8
Restarting gastrointestinal endoscopy in the deceleration and early recovery phases of COVID-19 pandemic: Guidance from the British Society of Gastroenterology.重启 COVID-19 大流行减速和早期复苏阶段的胃肠内镜检查:英国胃肠病学会的指南。
Clin Med (Lond). 2020 Jul;20(4):352-358. doi: 10.7861/clinmed.2020-0296. Epub 2020 Jun 9.
9
Managing the COVID-19 Pandemic as a National Radiation Oncology Centre in Singapore.作为新加坡的一家国家放射肿瘤学中心,管理 COVID-19 大流行。
Clin Oncol (R Coll Radiol). 2020 Jul;32(7):e155-e159. doi: 10.1016/j.clon.2020.04.006. Epub 2020 Apr 23.
10
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.SARS-CoV-2 在武汉一家三级医院癌症患者中的传播。
JAMA Oncol. 2020 Jul 1;6(7):1108-1110. doi: 10.1001/jamaoncol.2020.0980.